Non-Genetic Risk Stratification Model of Allopurinol induced Severe Cutaneous Adverse drug Reactions Prognostic Score (NoG-ASCAR Score)
Probability (Model 2): 1.83%
Moderate non-genetic risk of allopurinol induced severe cutaneous adverse drug reactions. HLA-B*58:01 genetic testing is required before allopurinol prescription. However, if the testing is negative result, monitoring of severe cutaneous adverse drug reactions is recommended after starting allopurinol.